Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. end stage renal disease
Show results for
Products
Applications

Companies

News
Articles
Videos

Refine by
Date

  • Older

End Stage Renal Disease Articles & Analysis

9 articles found

Will Metformin Be Replaced By SGLT-2 Inhibitors

Will Metformin Be Replaced By SGLT-2 Inhibitors

For patients with previous cardiovascular disease, the risk of myocardial infarction was also significantly reduced. 3. ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure

Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure

The use of peritoneal dialysis in the setting of refractory heart failure has long been described, and small studies have reported improvement in symptoms, quality of life, and neurohormonal activation in patients with refractory congestion despite high- dose loop diuretics.51 In a prospective observational study of 159 outpatients with refractory heart failure, peritoneal dialysis was associated ...

BySecond Heart Assist, Inc.


Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection

Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection

Consequently, bacterial infection is the second leading cause of death in hemodialysis patients with end-stage renal disease.10 Gram-positive Staphylococcus aureus is responsible for the majority of vascular access infections4,11 and subsequently linked to higher rates of patient mortality from serious medical complications ...

ByHumacyte, Inc.


An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia

An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia

Each year, more than 100,000 new end stage renal disease patients begin therapy on hemodialysis [1]. ...

ByHumacyte, Inc.


Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

Objective: Patients with end stage renal failure who require haemodialysis suffer morbidity and mortality due to vascular access. ...

ByHumacyte, Inc.


Artio’s Amplifi System Treatment Before AVF Creation Studied in FIH Procedures

Artio’s Amplifi System Treatment Before AVF Creation Studied in FIH Procedures

The prospective, nonrandomized, single-arm, open-label, FIH clinical study in five patients with end-stage renal disease was conducted at Sanatorio Italiano in Asunción, Paraguay, and commenced in Q4 2020. ...

ByArtio Medical, Inc.


LimFlow Percutaneous Deep Venous Arterialization

LimFlow Percutaneous Deep Venous Arterialization

They may have a lot of comorbidities—such as diabetes, chronic kidney disease, end-stage renal disease—and they’re complex cases. ...

ByLimFlow, Inc.


Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage

Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage

Keywords Vascular access · Hemodialysis · Healthcare costs · Health economics · Arteriovenous fistula · Arteriovenous graft Abstract Introduction: Hemodialysis (HD) in end-stage renal disease (ESRD) patients requires vascular access (VA) through an arteriovenous fistula (AVF), a prosthetic ...

ByHumacyte, Inc.


Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes

Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes

Keywords: Arteriovenous fistula, Haemodialysis, Patency, Maturation, Meta-analysis Introduction The use of chronic haemodialysis (HD) as renal replacement therapy (RRT) in patients with end stage renal disease (ESRD) is a prevalent practice worldwide and in the USA, and HD accounts for approximately 63% of ...

ByHumacyte, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT